What does ZICHEM PHARMA do?

ZICHEM PHARMA is a pharmacy in Scherpenheuvel-Zichem. Private Limited, started on 21 August 1987, 1 establishment.

What is the address of ZICHEM PHARMA?

The registered office of ZICHEM PHARMA is located at Markt 7, 3271 Scherpenheuvel-Zichem.

Is ZICHEM PHARMA still active?

Yes. According to the CBE (29 October 2026) ZICHEM PHARMA is active, legal situation “Normale toestand”, started on 21 August 1987.

Is ZICHEM PHARMA registered on Peppol?

Yes, ZICHEM PHARMA is registered on the Peppol network with ID 0208:0431802725.

What is the enterprise number of ZICHEM PHARMA?

The enterprise number of ZICHEM PHARMA is BE0431802725.

When was ZICHEM PHARMA founded?

ZICHEM PHARMA was founded on 21 August 1987.

Who are the directors of ZICHEM PHARMA?

According to the 2025 annual accounts, the directors of ZICHEM PHARMA are: Sodiap BV, Alexo BV, Hilde Braeken BV.

Is ZICHEM PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 August 1987; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did ZICHEM PHARMA make in 2025?

ZICHEM PHARMA posted a profit after taxes of € 40,263 in financial year 2025.

What is the revenue of ZICHEM PHARMA?

As a small company, ZICHEM PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 52,225.

Does ZICHEM PHARMA have a website?

Yes, ZICHEM PHARMA has a website at zichempharma.be.

ZICHEM PHARMA (Private Limited) - Scherpenheuvel-Zichem

Dossier ZICHEM PHARMA, printed on 29 October 2026 from databakkes.be/en/0431802725/zichem-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ZICHEM PHARMA from Scherpenheuvel-Zichem, company number BE0431802725, closed financial year 2025 with a result of € 40,263 after tax. For that financial year ZICHEM PHARMA recorded a gross margin of € 52,225 and equity of € 538,245. Compared with financial year 2024, the result moved from € 23,978 to € 40,263. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 538,245

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 40,263

▲ 68% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,119

▼ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 531,140.

People and assets in 2025

Wage cost

€ 360

▲ 256% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,351

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 80,732

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,429

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 84,256 Gross margin 2022: € 84,256 First fiscal year in the series	€ 73,979 Gross margin 2023: € 73,979 ▼ 12% vs 2022 (€ 84,256) Unfavourable step	€ 30,401 Gross margin 2024: € 30,401 ▼ 59% vs 2023 (€ 73,979) Unfavourable step	€ 52,225 Gross margin 2025: € 52,225 ▲ 72% vs 2024 (€ 30,401) Favourable step	▲ 72%
Profit after taxes	€ 58,923 Profit after taxes 2022: € 58,923 First fiscal year in the series	€ 55,074 Profit after taxes 2023: € 55,074 ▼ 7% vs 2022 (€ 58,923) Unfavourable step	€ 23,978 Profit after taxes 2024: € 23,978 ▼ 56% vs 2023 (€ 55,074) Unfavourable step	€ 40,263 Profit after taxes 2025: € 40,263 ▲ 68% vs 2024 (€ 23,978) Favourable step	▲ 68%
Equity	€ 418,931 Equity 2022: € 418,931 First fiscal year in the series	€ 474,005 Equity 2023: € 474,005 ▲ 13% vs 2022 (€ 418,931) Favourable step	€ 497,983 Equity 2024: € 497,983 ▲ 5% vs 2023 (€ 474,005) Favourable step	€ 538,245 Equity 2025: € 538,245 ▲ 8% vs 2024 (€ 497,983) Favourable step	▲ 8%
Total debts	€ 68,946 Total debts 2022: € 68,946 First fiscal year in the series	€ 133,672 Total debts 2023: € 133,672 ▲ 94% vs 2022 (€ 68,946) Unfavourable step	€ 89,690 Total debts 2024: € 89,690 ▼ 33% vs 2023 (€ 133,672) Favourable step	€ 84,161 Total debts 2025: € 84,161 ▼ 6% vs 2024 (€ 89,690) Favourable step	▼ 6%
Cash	€ 7,161 Cash 2022: € 7,161 First fiscal year in the series	€ 4,966 Cash 2023: € 4,966 ▼ 31% vs 2022 (€ 7,161) Unfavourable step	€ 5,569 Cash 2024: € 5,569 ▲ 12% vs 2023 (€ 4,966) Favourable step	€ 4,119 Cash 2025: € 4,119 ▼ 26% vs 2024 (€ 5,569) Unfavourable step	▼ 26%
Land & buildings	€ 39,709 Land & buildings 2022: € 39,709 First fiscal year in the series	€ 35,721 Land & buildings 2023: € 35,721 ▼ 10% vs 2022 (€ 39,709) Unchanged	€ 31,732 Land & buildings 2024: € 31,732 ▼ 11% vs 2023 (€ 35,721) Unchanged	€ 29,856 Land & buildings 2025: € 29,856 ▼ 6% vs 2024 (€ 31,732) Unchanged	▼ 6%
Retained profit	€ 411,826 Retained profit 2022: € 411,826 First fiscal year in the series	€ 466,900 Retained profit 2023: € 466,900 ▲ 13% vs 2022 (€ 411,826) Favourable step	€ 490,877 Retained profit 2024: € 490,877 ▲ 5% vs 2023 (€ 466,900) Favourable step	€ 531,140 Retained profit 2025: € 531,140 ▲ 8% vs 2024 (€ 490,877) Favourable step	▲ 8%
Balance sheet total	€ 487,877 Balance sheet total 2022: € 487,877 First fiscal year in the series	€ 607,677 Balance sheet total 2023: € 607,677 ▲ 25% vs 2022 (€ 487,877) Unchanged	€ 587,672 Balance sheet total 2024: € 587,672 ▼ 3% vs 2023 (€ 607,677) Unchanged	€ 622,406 Balance sheet total 2025: € 622,406 ▲ 6% vs 2024 (€ 587,672) Unchanged	▲ 6%

Key figures of ZICHEM PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ZICHEM PHARMA?

What happened at ZICHEM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 40,263 (▲ 68% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
2020 Hilde Braeken BV became a director. NBB
Sep 3, 1987 New establishment in Scherpenheuvel-Zichem. KBO
Aug 21, 1987 Start of the company according to the CBE. KBO

In short

From € 58,923 profit in 2022 to € 40,263 profit in 2025.

Paid € 59,442 in corporate taxes since 2022.

Best year ever: 2022, with € 58,923 profit.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ZICHEM PHARMA

Behind ZICHEM PHARMA are Sodiap BV, Alexo BV and Hilde Braeken BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, SANIFAR +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Hilde Braeken BV

Managing director · represented by Hilde Braeken

since 2020

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Markt 7

3271 Scherpenheuvel-Zichem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS zichempharma.be

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 106,028

Languages FR, NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0431.802.725

VAT number

BE 0431.802.725

Registered office

Markt 7, 3271 Scherpenheuvel-Zichem

Names & denominations

ZICHEM PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 August 1987

Peppol

Active · Active since 6 Jun 2025

Contact

zichempharma.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

ZICHEM PHARMA

Financials

What happened to ZICHEM PHARMA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions